Product Details

Verapara is a sterile, non-pyrogenic, preservative-free injectable formulation that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Paracetamol at 1g per 100ml for intravenous infusion in the management of pain and fever. As a result, it offers a fast-acting, non-opioid analgesic and antipyretic option for hospital and surgical settings.

The injection contains:

• Paracetamol IP (1g per 100ml) – A centrally acting analgesic and antipyretic that inhibits prostaglandin synthesis in the central nervous system. Consequently, it reduces pain and fever effectively while carrying a favourable safety profile compared to NSAIDs and opioids.

Physicians use Verapara for the short-term management of moderate pain, particularly when combined with opioid analgesics, and for the reduction of fever when an intravenous route is preferred or oral administration is not possible. In addition, its ready-to-use, single dose container format supports rapid administration during peri-operative and post-operative care. Because of this profile, Verapara suits hospitals, surgical units, and post-operative care settings where fast, reliable pain and fever control is needed.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the sterile, non-pyrogenic, preservative-free formulation supports safe IV infusion
• Furthermore, each single dose container delivers precise, validated dosage accuracy at 1g/100ml
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected packaging preserves product stability during storage
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, surgical units, and pharmacies